MaYinglong Pharmaceutical Group Co. Ltd. | Cash Flow
Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
177,675.60
192,270.00
210,943.50
232,997.40
308,845.80
164,558.10
Depreciation, Depletion & Amortization
33,115.30
39,363.10
33,305.60
45,462.30
45,448.80
46,246.10
Other Funds
4,222.90
485.20
20,213.80
4,800.10
1,491.90
142,485.80
Funds from Operations
206,504.00
220,900.70
250,419.90
258,592.90
286,185.80
329,390.90
Changes in Working Capital
76,564.40
107,972.90
46,677.50
18,652.40
70,892.30
19,869.20
Net Operating Cash Flow
129,939.60
112,927.90
203,742.50
239,940.50
357,078.10
309,521.60
Capital Expenditures
83,677.60
106,872.60
123,929.20
65,236.20
41,599.80
Sale of Fixed Assets & Businesses
3,611.00
21,392.70
61.40
20,317.80
71,423.80
Purchase/Sale of Investments
11,957.70
113,279.50
161,254.00
239,183.80
91,222.00
Net Investing Cash Flow
90,024.30
202,142.20
281,585.10
279,282.20
121,046.00
Cash Dividends Paid - Total
53,052.80
56,368.60
13,263.20
86,210.80
86,210.80
Issuance/Reduction of Debt, Net
3,490.00
27,500.00
13,000.00
53,000.00
3,800.00
Net Financing Cash Flow
52,319.90
28,383.40
19,950.60
38,010.90
88,518.90
Net Change in Cash
12,739.50
117,381.00
56,316.00
76,261.20
387,578.40
Free Cash Flow
46,262.00
6,055.30
79,813.30
174,704.20
315,478.30
Deferred Taxes & Investment Tax Credit
2,594.10
1,358.30
1,571.90
2,272.40
5,994.90
23,899.20
Net Assets from Acquisitions
-
10,082.80
-
3,600.00
-
Other Sources
2,000.00
6,700.00
8,700.00
8,420.00
-
Exchange Rate Effect
334.80
216.80
1,576.00
1,091.40
2,026.80
Other Uses
-
-
5,163.30
-
-
About MaYinglong Pharmaceutical Group Co.
View Profile
